The Technical AnalystExchange: PNK Industry: Medical Instruments & Supplies
Remedent, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0550
America/New_York / 12 apr 2024 @ 13:41
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1.100 mill |
| EPS: | -0.0100 |
| P/E: | -5.50 |
| Earnings Date: | May 29, 2024 |
| SharesOutstanding: | 20.00 mill |
| Avg Daily Volume: | 0.0015 mill |
| RATING 2024-04-12 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -5.50 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -5.50 | industry: PE -6.22 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.0426 (-22.63%) $-0.0124 |
| Date: 2024-04-17 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0490 - 0.0610 ( +/- 10.91%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2015-12-02 | Sternberg Stuart | Buy | 399 819 | Common Stock, no par value |
| 2015-12-02 | Sternberg Stuart | Buy | 399 819 | Common Stock, no par value |
| 2013-07-24 | Sternberg Stuart | Sell | 0 | Common Stock, no par value |
| 2013-07-24 | Marxe Austin W & Greenhouse David M | Sell | 2 848 408 | Common Stock |
| 2013-07-18 | Marxe Austin W & Greenhouse David M | Sell | 225 000 | Common Stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 95 transactions |
| Buy: 18 183 711 | Sell: 15 334 216 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0550 (0.00% ) |
| Volume | 0.0010 mill |
| Avg. Vol. | 0.0015 mill |
| % of Avg. Vol | 66.49 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For REMI
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
REMI
Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. It also provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. In addition, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice, which enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Further, it provides dental implant solutions and treatment concepts. The company sells its products to dental professionals in approximately 30 countries, including Asia, Europe, the Middle East, Canada, and the United States through its internal sales force and third party distributors. The company was founded in 1986 and is headquartered in Ghent, Belgium.